发明名称 |
CRYSTALLINE FORMS OF N,N-DICYCLOPROPYL-4-(1,5-DIMETHYL-1H-PYRAZOL-3-YLAMINO)-6-ETHYL-1-METHYL-1,6-DIHYDROIMIDAZO[4,5-D]PYRROLO[2,3-B]PYRIDINE-7-CARBOXIMIDE FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS |
摘要 |
Crystalline form, Form T1H1.5-4, of N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl -1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide (Compound (I)) is provided. Also provided is a pharmaceutical composition and an oral dosage form comprising Form T1H1.5-4 of Compound (I) as well as a method of using the Form T1H1.5-4 of Compound for the treatment of myeloproliferative disorders, which include polycythaemia vera, thrombocythaemia and primary myelofibrosis.; |
申请公布号 |
US2016090385(A1) |
申请公布日期 |
2016.03.31 |
申请号 |
US201414892622 |
申请日期 |
2014.05.28 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
Purandare Ashok Vinayak;Wan Honghe |
分类号 |
C07D471/14 |
主分类号 |
C07D471/14 |
代理机构 |
|
代理人 |
|
主权项 |
1. A crystalline form of Compound I: comprising Form T1H1.5-4. |
地址 |
Princeton NJ US |